Important MeSH terms and keywords used were: glucagon-like peptide 1 (GLP-1), GLP-1 analogue, incretin, dipeptidyl peptidase 4 (DPP-4) inhibitor, atherosclerosis, arteriosclerosis, atherogenesis, plaque, intima media thickness (IMT), flow-mediated dilation (FMD), adiponectin, leptin, endothelin, E-selectin, resistin, pentraxin, brain natriuretic peptide (BNP), monocyte chemotactic protein (MCP), vascular cell adhesion molecule-1 (VCAM-1), plasminogen activator inhibitor-1 (PAI-1), tumor necrosis factor-alpha (TNF-), interleukin-6 (IL-6), high sensitivity C-reactive protein (hs-CRP), triglyceride and cholesterol
A peptide named for a riddle it has yet to fully explain
Other improvements include enhanced automated Prior Authorization (PA) processing for GLP-1 agonists used for diabetes
This isnt a barrier to donating, but it requires an intentional plan going in
Cardiometabolic Exercise Framework Physical activity enhances the metabolic benefits of GLP-1s and protects cardiovascular health
GLP-1 drugs can lead to significant weight loss and improved glycemic control, which, while generally beneficial, may stress the optic nerve in susceptible individuals